Recommendations for Design, Execution, and Reporting of Studies on Experimental Thoracic Aortopathy in Preclinical Models

doi:10.1161/ATVBAHA.124.320259

Recommendations for Design, Execution, and Reporting of Studies on Experimental Thoracic Aortopathy in Preclinical Models

Producción científica: Review article › revisión exhaustiva

3 Citas (Scopus)

Resumen

There is a recent dramatic increase in research on thoracic aortic diseases that includes aneurysms, dissections, and rupture. Experimental studies predominantly use mice in which aortopathy is induced by chemical interventions, genetic manipulations, or both. Many parameters should be deliberated in experimental design in concert with multiple considerations when providing dimensional data and characterization of aortic tissues. The purpose of this review is to provide recommendations on guidance in (1) the selection of a mouse model and experimental conditions for the study, (2) parameters for standardizing detection and measurements of aortic diseases, (3) meaningful interpretation of characteristics of diseased aortic tissue, and (4) reporting standards that include rigor and transparency.

Idioma original	English
Páginas (desde-hasta)	609-631
Número de páginas	23
Publicación	Arteriosclerosis, Thrombosis, and Vascular Biology
Volumen	45
N.º	5
DOI	https://doi.org/10.1161/ATVBAHA.124.320259
Estado	Published - may 1 2025

Nota bibliográfica

Publisher Copyright:
© 2025 American Heart Association, Inc.

Financiación

The authors are funded by the Leducq Foundation Network of Excellence (22CVD03). Other supports include National Institutes of Health grants R01HL109942 (D.M. Milewicz), R01HL158157 (Y.H. Shen and S.A. LeMaire), R01HL159988 (Y.H. Shen, K.B. Ghaghada, and S.A. LeMaire), U01HL142518, R01HL155105, R01HL169147 (J.D. Humphrey), and R35HL155649 (A. Daugherty). The authors were supported by the following American Heart Association awards: 19MERIT34480009 (D.M. Milewicz), 23MERIT1036341 (A. Daugherty), 24CDA1268148 (H. Sawada), and 23IPA1054637 (K.B. Ghaghada). Other grants include the British Heart Foundation (G101517 and RG96157 to Z. Mallat and T. Suzuki), National Institute for Health and Care Research, United Kingdom (T. Suzuki), and the Marfan Foundation (K.B. Ghaghada and Y. Li).

Financiadores	Número del financiador
National Institute for Health and Care Research
National Marfan Foundation
British Heart Foundation	RG96157, G101517
British Heart Foundation
American the American Heart Association	19MERIT34480009, 23MERIT1036341, 24CDA1268148, 23IPA1054637
American the American Heart Association
National Institutes of Health (NIH)	R01HL155105, R01HL158157, R01HL169147, U01HL142518, R01HL159988, R01HL109942, R35HL155649
National Institutes of Health (NIH)
Leducq Foundation Network of Excellence	22CVD03

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Acceder al documento

10.1161/ATVBAHA.124.320259

Otros archivos y enlaces

Citar esto

@article{54f93ce846014246ae83ebd7fcc2f5c4,

title = "Recommendations for Design, Execution, and Reporting of Studies on Experimental Thoracic Aortopathy in Preclinical Models",

abstract = "There is a recent dramatic increase in research on thoracic aortic diseases that includes aneurysms, dissections, and rupture. Experimental studies predominantly use mice in which aortopathy is induced by chemical interventions, genetic manipulations, or both. Many parameters should be deliberated in experimental design in concert with multiple considerations when providing dimensional data and characterization of aortic tissues. The purpose of this review is to provide recommendations on guidance in (1) the selection of a mouse model and experimental conditions for the study, (2) parameters for standardizing detection and measurements of aortic diseases, (3) meaningful interpretation of characteristics of diseased aortic tissue, and (4) reporting standards that include rigor and transparency.",

keywords = "aneurysm, aorta, dissection, mice, research design",

author = "Alan Daugherty and Milewicz, \{Dianna M.\} and Dichek, \{David A.\} and Ghaghada, \{Ketan B.\} and Humphrey, \{Jay D.\} and Lemaire, \{Scott A.\} and Yanming Li and Ziad Mallat and Yvan Saeys and Hisashi Sawada and Shen, \{Ying H.\} and Toru Suzuki and Zhen Zhou",

note = "Publisher Copyright: {\textcopyright} 2025 American Heart Association, Inc.",

year = "2025",

month = may,

day = "1",

doi = "10.1161/ATVBAHA.124.320259",

language = "English",

volume = "45",

pages = "609--631",

number = "5",

}

TY - JOUR

T1 - Recommendations for Design, Execution, and Reporting of Studies on Experimental Thoracic Aortopathy in Preclinical Models

AU - Daugherty, Alan

AU - Milewicz, Dianna M.

AU - Dichek, David A.

AU - Ghaghada, Ketan B.

AU - Humphrey, Jay D.

AU - Lemaire, Scott A.

AU - Li, Yanming

AU - Mallat, Ziad

AU - Saeys, Yvan

AU - Sawada, Hisashi

AU - Shen, Ying H.

AU - Suzuki, Toru

AU - Zhou, Zhen

PY - 2025/5/1

Y1 - 2025/5/1

N2 - There is a recent dramatic increase in research on thoracic aortic diseases that includes aneurysms, dissections, and rupture. Experimental studies predominantly use mice in which aortopathy is induced by chemical interventions, genetic manipulations, or both. Many parameters should be deliberated in experimental design in concert with multiple considerations when providing dimensional data and characterization of aortic tissues. The purpose of this review is to provide recommendations on guidance in (1) the selection of a mouse model and experimental conditions for the study, (2) parameters for standardizing detection and measurements of aortic diseases, (3) meaningful interpretation of characteristics of diseased aortic tissue, and (4) reporting standards that include rigor and transparency.

AB - There is a recent dramatic increase in research on thoracic aortic diseases that includes aneurysms, dissections, and rupture. Experimental studies predominantly use mice in which aortopathy is induced by chemical interventions, genetic manipulations, or both. Many parameters should be deliberated in experimental design in concert with multiple considerations when providing dimensional data and characterization of aortic tissues. The purpose of this review is to provide recommendations on guidance in (1) the selection of a mouse model and experimental conditions for the study, (2) parameters for standardizing detection and measurements of aortic diseases, (3) meaningful interpretation of characteristics of diseased aortic tissue, and (4) reporting standards that include rigor and transparency.

KW - aneurysm

KW - aorta

KW - dissection

KW - mice

KW - research design

UR - https://www.scopus.com/pages/publications/105000287016

UR - https://www.scopus.com/pages/publications/105000287016#tab=citedBy

U2 - 10.1161/ATVBAHA.124.320259

DO - 10.1161/ATVBAHA.124.320259

M3 - Review article

C2 - 40079138

AN - SCOPUS:105000287016

SN - 1079-5642

VL - 45

SP - 609

EP - 631

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

IS - 5

ER -

Recommendations for Design, Execution, and Reporting of Studies on Experimental Thoracic Aortopathy in Preclinical Models

Resumen

Nota bibliográfica

Financiación

ASJC Scopus subject areas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto